GREENAccessories

Reconstitution Water

Reconstitution Water (Bacteriostatic Water for Injection, USP)

Research compound2 SKUs available
MedTech Research Group

MedTech Research Group

Research Hub — Aggregated Studies

MedTech Research Group aggregates published research from peer-reviewed journals, clinical trials, and academic institutions. We do not conduct original research. All studies cited below are the work of their respective authors and institutions. Sources are linked for verification.

This product is designated FOR RESEARCH USE ONLY (RUO). These compounds have not been approved or cleared under 21 U.S.C. § 505 and have not been evaluated by the FDA for safety, efficacy, or labeling for clinical, diagnostic, or therapeutic use in humans or animals.

MedTech Research Group will only fulfill orders to qualified researchers affiliated with accredited academic institutions, licensed research facilities, or organizations with active IRB/IACUC oversight.

Purchaser Restrictions

  • Purchaser must be a qualified researcher at an accredited institution or licensed research facility
  • This product may not be sold or redistributed to individual consumers, wellness clinics, health food stores, or retail establishments
  • Not intended for human or animal consumption, diagnostic use, or therapeutic application
  • Institutional affiliation and research purpose will be verified prior to order fulfillment

Distribution is limited to qualified research use in compliance with applicable federal and state law. These products bear the "For Research Use Only" designation per FDA labeling requirements (minimum 10 pt. font). Ref: 21 U.S.C. § 505; FD&C Act § 201(p) (unapproved new drug definition).

Compound Overview
Risk TierGREEN
CategoryAccessories
SubcategoryReconstitution Supply
Pharmacological ClassN/A (Diluent)
SubclassBacteriostatic Water for Injection
Molecular TypeSterile water with 0.9% benzyl alcohol (bacteriostatic preservative)
OriginPharmaceutical-grade sterile water with preservative
Regulatory StatusFDA-regulated as a pharmaceutical diluent. USP-grade.
Route of AdministrationUsed as a diluent for reconstituting lyophilized peptides, hormones, and other injectable products
ReconstitutionN/A — this IS the reconstitution medium
StorageRoom temperature (15-30°C); do not freeze
Detailed Research

Description

Reconstitution Water (Bacteriostatic Water for Injection, USP) is sterile water containing 0.9% benzyl alcohol as a bacteriostatic preservative. It is the standard diluent used for reconstituting lyophilized (freeze-dried) peptides, hormones, and other injectable products throughout this catalog. Bacteriostatic water differs from Sterile Water for Injection (SWFI) in one critical respect: the benzyl alcohol preservative inhibits the growth of most bacteria that might be introduced during repeated needle entries into a multi-dose vial. SWFI lacks this preservative and must be used immediately after opening (single-use), while bacteriostatic water can be used for up to 28 days after first puncture when stored properly.

The 0.9% benzyl alcohol concentration is the standard USP concentration — sufficient to prevent microbial growth but low enough to avoid tissue toxicity at the injection volumes used with peptides. When reconstituting lyophilized peptides, the bacteriostatic water is slowly injected down the side of the vial (not directly onto the peptide cake) and the vial is gently swirled (never shaken) to dissolve the powder. The reconstituted solution should be clear and free of particulates before use.

Clinical Context

Bacteriostatic water is an essential supply item that accompanies nearly every lyophilized product in this catalog. The two vial sizes serve different needs: the 3ml vial ($7.03) is sufficient for reconstituting 1–2 peptide vials at standard concentrations, while the 10ml vial ($9.82) is more economical for reconstituting multiple products. Proper reconstitution technique is essential for maintaining peptide stability and sterility — improper technique (shaking, contamination, wrong volume) can denature peptides or introduce bacterial contamination.

Research Applications
Reconstitution of all lyophilized peptide products
Multi-dose vial preparation (bacteriostatic preservative allows repeated access)
Standard pharmaceutical diluent in research settings
Clinician Notes
Important Notes for Clinicians
  • CONTAINS BENZYL ALCOHOL (0.9%) — contraindicated in neonates and infants (benzyl alcohol toxicity/"gasping syndrome"); use Sterile Water for Injection (SWFI) instead for pediatric patients
  • 28-day beyond-use date after first needle puncture — discard after 28 days regardless of remaining volume
  • Do not freeze — freezing and thawing can compromise sterility
  • Always use aseptic technique when drawing from the vial — swab the stopper with alcohol before each needle entry
  • When reconstituting peptides: inject water slowly down the side of the vial, never directly onto the lyophilized cake; swirl gently, never shake
  • The 10ml vial ($9.82) is significantly more cost-effective than the 3ml vial ($7.03) for multi-product reconstitution
  • Reconstituted peptide solutions should be refrigerated (2-8°C) and used within the peptide manufacturer's recommended timeframe (typically 2-4 weeks)
  • Visual inspection: the reconstituted solution should be clear, colorless, and free of visible particulates — discard if cloudy, discolored, or particulate

Published Research

Published Research & Clinical Data

Peer-reviewed studies and clinical trial data related to Reconstitution Water

All research below is conducted by independent institutions. MedTech Research Group provides these references for informational purposes only.

Research citations are being compiled for this compound.

Check back soon — our team is curating peer-reviewed sources.